Back to Browse Journals » Patient Preference and Adherence » Volume 6

Improving patient–physician dialog: commentary on the results of the MS Choices survey

Authors Lugaresi A, Ziemssen T, Oreja-Guevara C, Thomas D, Verdun E

Published Date February 2012 Volume 2012:6 Pages 143—152

DOI http://dx.doi.org/10.2147/PPA.S27932

Received 4 November 2011, Accepted 6 December 2011, Published 17 February 2012

Alessandra Lugaresi1, Tjalf Ziemssen2, Celia Oreja-Guevara3, Delyth Thomas4, Elisabetta Verdun5

1Department of Neuroscience and Imaging, University "G d'Annunzio", Chieti, Italy; 2Center of Clinical Neuroscience, Neurological University Clinic, Dresden University of Technology, Dresden, Germany; 3Multiple Sclerosis Unit, Department of Neurology, Health Research Institute (IdiPAZ), University Hospital La Paz, Madrid, Spain; 4Wye Valley NHS Trust, Hereford, United Kingdom; 5Global Medical Affairs Neurology, Merck Serono S.A. – Geneva, Switzerland

Abstract: Achieving good long- and short-term adherence to treatment for chronic diseases is important if patients are to gain the full benefits of treatment. Several barriers to adherence in multiple sclerosis (MS) have been identified and the healthcare team should work with patients to help them to overcome these obstacles. The MS Choices survey explored patient and physician perspectives on key aspects of MS diagnosis, treatment adherence, and disease management with the aim of improving understanding of the factors that influence patient behavior regarding treatment adherence. The survey found some important differences between patient and physician responses and here these findings are discussed in the context of personal clinical experience. Further, the possible implications of these findings for routine practice have been considered, and strategies that should be employed by MS physicians and nurses to help patients to adhere to their prescribed treatment are suggested.

Keywords: multiple sclerosis, treatment adherence, treatment initiation, patient–physician dialog, psychological profiling

Download Article [PDF] View Full Text [HTML] 

Creative Commons License This work is published by Dove Medical Press Limited, and licensed under Creative Commons Attribution - Non Commercial (unported, v3.0) License. The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0/. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. Permissions beyond the scope of the License are administered by Dove Medical Press Limited. Information on how to request permission may be found at: http://www.dovepress.com/permissions.php

Other article by this author:

Risk-benefit considerations in the treatment of relapsing-remitting multiple sclerosis

Lugaresi A, di Ioia M, Travaglini D, Pietrolongo E, Pucci E, Onofrj M

Neuropsychiatric Disease and Treatment 2013, 9:893-914

Published Date: 24 June 2013

Readers of this article also read:

Long-term outcomes of pediatric hypospadias and surgical intervention

De Win G, Cuckow P, Hoebeke P, Wood D

Pediatric Health, Medicine and Therapeutics 2012, 3:69-77

Published Date: 18 October 2012

Patient perceptions of multiple sclerosis and its treatment

de Seze J, Borgel F, Brudon F

Patient Preference and Adherence 2012, 6:263-273

Published Date: 4 April 2012

The MS Choices Survey: findings of a study assessing physician and patient perspectives on living with and managing multiple sclerosis

Riñon A, Buch M, Holley D, Verdun E

Patient Preference and Adherence 2011, 5:629-643

Published Date: 28 December 2011

Role of aliskiren in cardio-renal protection and use in hypertensives with multiple risk factors

Eduardo Pimenta, Suzanne Oparil

Vascular Health and Risk Management 2009, 5:453-463

Published Date: 19 May 2009